Is the Response of Serum Lipids and Lipoproteins to Postmenopausal Hormone Replacement Therapy Modified by ApoE Genotype?
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (2) , 402-407
- https://doi.org/10.1161/01.atv.19.2.402
Abstract
Abstract —Postmenopausal hormone replacement therapy (HRT) has favorable effects on the serum lipid profile, and it also decreases the risk of cardiovascular diseases. The apolipoprotein E genotype has influence on serum levels of lipids and lipoproteins; apoE allele ε4 (apoE4) is associated with high total and LDL cholesterol levels. Genotype also influences the lipid responses to treatment with diet and statins, but the effect of HRT in different apoE genotypes is unknown. We studied the effects of HRT on the concentrations of serum lipids in apoE4-positive early postmenopausal women (genotypes 3/4 and 4/4) compared with apoE4-negative women (genotypes 2/3 and 3/3) in a population-based, prospective 5-year study. In all, 232 early postmenopausal women were randomized into 2 treatment groups: an HRT group (n=116), which received a sequential combination of 2 mg estradiol valerate (E 2 Val) from day 1 to 21 and 1 mg cyproterone acetate (CPA) from day 12 to 21 (Climen), and a placebo group (n=116), which received 500 mg/d calcium lactate. Serum concentrations of total, LDL, and HDL cholesterol and triglycerides were measured at baseline and after 2 and 5 years of treatment. A total of 154 women completed the final analysis. During the follow-up period, serum total cholesterol and LDL cholesterol concentrations decreased in the HRT group in apoE4-negative women (8.1% and 17.1%, respectively; P P =0.015; apoE4-positive, 8.1%, P =0.004) but did not change significantly in the HRT group. Serum triglyceride levels tended to increase in both study groups and genotypes (15.1% to 36.2%, P <0.038 to 0.001), but no differences were observed between the study groups or genotypes, respectively. Our finding was that in postmenopausal Finnish women LDL cholesterol levels in apoE4-negative subjects respond more favorably to HRT than those in apoE4-positive subjects. This finding has potential importance in postmenopausal women with hypercholesterolemia, if confirmed in other studies.Keywords
This publication has 15 references indexed in Scilit:
- A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locusAtherosclerosis, 1997
- Changes in Diet in Finland from 1972 to 1992: Impact on Coronary Heart Disease RiskPreventive Medicine, 1996
- The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphismMetabolism, 1993
- Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whitesAtherosclerosis, 1993
- The fatty acid and cholesterol content of the average finnish dietJournal of Food Composition and Analysis, 1992
- Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma LipoproteinsNew England Journal of Medicine, 1991
- Apolipoprotein E polymorphism influences the serum cholesterol response to dietary interventionMetabolism, 1991
- Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/ progestogen therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988
- Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterolScandinavian Journal of Clinical and Laboratory Investigation, 1981